Ontario Institute for Cancer Research (oicr)

Canada

 
Quantité totale PI 81
Rang # Quantité totale PI 16 437
Note d'activité PI 2,6/5.0    54
Rang # Activité PI 13 438

Brevets

Marques

20 0
20 0
41 0
0
 
Dernier brevet 2025 - Pan-cancer transcriptional signa...
Premier brevet 2011 - Thermosensitive liposomes

Derniers inventions, produits et services

2023 Invention Methods and systems for characterization, diagnosis, and treatment of cancer. Disclosed herein ar...
Invention Quinazoline derivatives as inhibitors of the gcn2 kinase, compositions and uses thereof. The pres...
Invention Isoquinoline derivatives as inhibitors of bax and/or bak, compositions and uses thereof. The pres...
2022 Invention Mitochondrial dna prostate cancer marker and related systems and methods. There is described her...
Invention Halo-substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor ki...
Invention Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1...
Invention Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase ...
Invention Compounds, compositions and methods of treating cancer. The present application relates to halo-s...
Invention Substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk...
Invention Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses ther...
Invention Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and ...
2021 Invention Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof. The presen...
Invention Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof. The present...
Invention Molecular classifiers for prostate cancer. There is described herein a method of predicting dise...
Invention Molecular classifiers for prostate cancer. There is described herein a method of predicting disea...
2020 Invention Unsaturated heterocycloalkyl and heteroaromatic acyl hydrazone linkers, methods and uses thereof....
Invention Pan-cancer transcriptional signature. There is described herein a pan-cancer transcriptional sig...
Invention Pan-cancer transcriptional signature. There is described herein a pan-cancer transcriptional sign...
Invention Amide-based proteolysis modulators of b-rapidly accelerated fibrosarcoma (braf) and associated us...
2019 Invention Compounds and methods for treating nematode infections. The present application relates to the tr...
Invention Substituted heteroaryls as inhibitors of the bcl6 btb domain protein-protein interaction. The pre...
Invention Inhibitors of the bcl6 btb domain protein-protein interaction and uses thereof. The present appli...
2018 Invention Tricyclic inhibitors of the bcl6 btb domain protein-protein interaction and uses thereof. The pre...
Invention Deuterated compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/or as b...
Invention Novel deuterated compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/o...
Invention Heterocyclic acyl hydrazone linkers, methods and uses thereof. The present application is directe...
Invention Quinolone compounds as inhibitors of the bcl6 btb domain protein-protein interaction and/or as bc...
Invention Quinolone compounds as inhibitors of the bcl6 btb domain protein-p rotein interaction and/or as b...
Invention Acyl hydrazone linkers, methods and uses thereof. The present application is directed to compound...